Skip to main content
HR 3627 109th Congress House Health Administrative procedure Animals Armed Forces and National Security Automation Biological warfare Biotechnology Clinical trials Colleges Commerce Communicable diseases Communication in medicine Communication in science Computer simulation Computer software Congress Congressional reporting requirements Crime and Law Enforcement Defense contracts Defense procurement

Rapid Pathogen Identification to Delivery of Cures Act

Introduced: July 29, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 19, 2005
Referred to the Subcommittee on Terrorism, Unconventional Threats and Capabilities.
Aug 22, 2005
Referred to the Subcommittee on Emergency Preparedness, Science, and Technology.
Aug 5, 2005
Referred to the Subcommittee on Health.
Jul 29, 2005
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 29, 2005
Sponsor introductory remarks on measure. (CR E1712)
Jul 29, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Rapid Pathogen Identification to Delivery of Cures Act - Amends the Homeland Security Act of 2002 to require the Secretary of Homeland Security to submit a report setting forth a strategy to reduce the time frame from pathogen identification to the development and emergency approval for human use of a reasonably safe and effective priority countermeasure against a novel or unknown pathogen or toxin. Requires the report to include: (1) technical impediments to reducing this time frame; (2) research, development, and technology needs to address these impediments; and (3) potential liability concerns stemming from distribution of rapidly-developed priority countermeasures.

Allows the Secretary to contract with any firm or institution to conduct necessary research and analysis for this report.

Requires the Secretary of Health and Human Services (HHS) to establish a system to rapidly: (1) establish clinical research programs to examine the safety and efficacy of treatments for novel, unknown, or bioengineered pathogens or toxins; and (2) disseminate results and recommendations to clinicians. Authorizes establishment of a fund to support such clinical research.

Requires the Secretary of Homeland Security to establish an interagency working group to carry out this Act.

Amends the Public Health Service Act to require the Secretary of HHS to conduct research to rapidly identify, develop, produce, and approve for human use priority countermeasures.

Requires the Secretaries of Defense and HHS to carry out research, development, and procurement to provide the federal government with the capability to rapidly identify, develop, produce, and approve for human use under emergency conditions priority countermeasures against a novel, unknown, or engineered pathogen or toxin for which no existing countermeasure has been determined to be safe or efficacious.

What's happening now September 19, 2005

Referred to the Subcommittee on Terrorism, Unconventional Threats and Capabilities.

 Committees of jurisdiction 6
 Cosponsors 2
All 2 Democratic 2